Sirolimus therapy for fetal cardiac rhabdomyoma in a pregnant woman with tuberous sclerosis

Sirolimus therapy for fetal cardiac rhabdomyoma in a pregnant woman with tuberous sclerosis

Rhabdomyoma is the most common fetal cardiac tumor, and its development is related to tuberous sclerosis. Fetal cardiac rhabdomyomas often spontaneously regress in utero or after birth, but large tumors can cause hemodynamic obstruction. Sirolimus, a mammalian target of rapamycin (mTOR) inhibitor, h...

Full description

Bibliographic Details
Main Authors: Hyea Park, Chi Son Chang, Suk-Joo Choi, Soo-young Oh, Cheong-Rae Roh
Format: Article
Language:English
Published: Korean Society of Obstetrics and Gynecology 2019-07-01
Series:Obstetrics & Gynecology Science
Subjects:
sirolimus
cardiac tumor
rhabdomyoma
tuberous sclerosis
fetal therapy
Online Access:http://ogscience.org/upload/pdf/ogs-62-280.pdf

Similar Items

Similar Items